Clinical Trial Update: A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing taspoglutide to insulin glargine in insulin-naïve Type 2 diabetes patients inadequately controlled on metformin and sulfonylurea, whic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Taspoglutide (taspoglutide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: TERMINATED